According to A Latest intelligence report published by Market IntelliX, the global market for Solid Dosage Form Drug should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

China Solid Dosage Form Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

The United States Solid Dosage Form Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

In terms of type, Tablet segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospital has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.

The global key manufacturers of Solid Dosage Form Drug include Johnson & Johnson, Novartis, Roche, AbbVie, Merck & Co., Bristol Myers Squibb, GlaxoSmithKline, Pfizer and Sanofi, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.

Solid dosage form means any of the many pharmacy dosage forms like tablets, capsules, caplets, pills, powders, troches, lozenges, cachets, pellets or confections which are solid and which are not in liquid or gaseous form.

This report aims to provide a comprehensive study of the global market for Solid Dosage Form Drug. Report Highlights:

(1) Global Solid Dosage Form Drug market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.

(2) Global Solid Dosage Form Drug market competitive situation, revenue and market share, from 2018 to 2022.

(3) China Solid Dosage Form Drug market competitive situation, revenue and market share, from 2018 to 2022.

(4) Global Solid Dosage Form Drug segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Solid Dosage Form Drug segment by type and by application and regional segment by type and by application.

(6) Solid Dosage Form Drug industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Tablet

Capsules

Other

Market segment by application, can be divided into

Hospital

Retail Pharmacy

Other

Market segment by players, this report covers

Johnson & Johnson

Novartis

Roche

AbbVie

Merck & Co.

Bristol Myers Squibb

GlaxoSmithKline

Pfizer

Sanofi

Takeda

AstraZeneca

Bayer

Eli Lilly & Co.

Gilead Sciences

Amgen

Teva

Boehringer Ingelheim

Biogen

Astellas

1 Market Overview

1.1 Product Overview and Scope of Solid Dosage Form Drug

1.2 Global Solid Dosage Form Drug Market Size and Forecast

1.3 China Solid Dosage Form Drug Market Size and Forecast

1.4 China Market Percentage in Global

1.4.1 By Revenue, China Solid Dosage Form Drug Share in Global Market, 2018-2029

1.4.2 Solid Dosage Form Drug Market Size: China VS Global, 2018-2029

1.5 Solid Dosage Form Drug Market Dynamics

1.5.1 Solid Dosage Form Drug Market Drivers

1.5.2 Solid Dosage Form Drug Market Restraints

1.5.3 Solid Dosage Form Drug Industry Trends

1.5.4 Solid Dosage Form Drug Industry Policy

2 Global Competitive Situation by Company

2.1 Global Solid Dosage Form Drug Revenue by Company (2018-2023)

2.2 Global Solid Dosage Form Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.3 Global Solid Dosage Form Drug Concentration Ratio

2.4 Global Solid Dosage Form Drug Mergers & Acquisitions, Expansion Plans

2.5 Global Solid Dosage Form Drug Manufacturers Product Type

3 China Competitive Situation by Company

3.1 China Solid Dosage Form Drug Revenue by Company (2018-2023)

3.2 China Solid Dosage Form Drug Solid Dosage Form Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.3 China Solid Dosage Form Drug, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)

4 Industry Chain Analysis

4.1 Solid Dosage Form Drug Industry Chain

4.2 Solid Dosage Form Drug Upstream Analysis

4.3 Solid Dosage Form Drug Midstream Analysis

4.4 Solid Dosage Form Drug Downstream Analysis

5 Sights by Type

5.1 Solid Dosage Form Drug Classification

5.1.1 Tablet

5.1.2 Capsules

5.1.3 Other

5.2 By Type, Global Solid Dosage Form Drug Market Size & CAGR, 2018 VS 2022 VS 2029

5.3 By Type, Global Solid Dosage Form Drug Revenue, 2018-2029

6 Sights by Application

6.1 Solid Dosage Form Drug Segment by Application

6.1.1 Hospital

6.1.2 Retail Pharmacy

6.1.3 Other

6.2 By Application, Global Solid Dosage Form Drug Market Size & CAGR, 2018 VS 2022 VS 2029

6.3 By Application, Global Solid Dosage Form Drug Revenue, 2018-2029

7 Sales Sights by Region

7.1 By Region, Global Solid Dosage Form Drug Market Size, 2018 VS 2022 VS 2029

7.2 By Region, Global Solid Dosage Form Drug Market Size, 2018-2029

7.3 North America

7.3.1 North America Solid Dosage Form Drug Market Size & Forecasts, 2018-2029

7.3.2 By Country, North America Solid Dosage Form Drug Market Size Market Share

7.4 Europe

7.4.1 Europe Solid Dosage Form Drug Market Size & Forecasts, 2018-2029

7.4.2 By Country, Europe Solid Dosage Form Drug Market Size Market Share

7.5 Asia Pacific

7.5.1 Asia Pacific Solid Dosage Form Drug Market Size & Forecasts, 2018-2029

7.5.2 By Country/Region, Asia Pacific Solid Dosage Form Drug Market Size Market Share

7.6 South America

7.6.1 South America Solid Dosage Form Drug Market Size & Forecasts, 2018-2029

7.6.2 By Country, South America Solid Dosage Form Drug Market Size Market Share

7.7 Middle East & Africa

8 Sights by Country Level

8.1 By Country, Global Solid Dosage Form Drug Market Size & CAGR，2018 VS 2022 VS 2029

8.2 By Country, Global Solid Dosage Form Drug Market Size, 2018-2029

8.3 U.S.

8.3.1 U.S. Solid Dosage Form Drug Market Size, 2018-2029

8.3.2 By Company, U.S. Solid Dosage Form Drug Revenue Market Share, 2018-2023

8.3.3 By Type, U.S. Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029

8.3.4 By Application, U.S. Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029

8.4 Europe

8.4.1 Europe Solid Dosage Form Drug Market Size, 2018-2029

8.4.2 By Company, Europe Solid Dosage Form Drug Revenue Market Share, 2018-2023

8.4.3 By Type, Europe Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029

8.4.4 By Application, Europe Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029

8.5 China

8.5.1 China Solid Dosage Form Drug Market Size, 2018-2029

8.5.2 By Company, China Solid Dosage Form Drug Revenue Market Share, 2018-2023

8.5.3 By Type, China Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029

8.5.4 By Application, China Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029

8.6 Japan

8.6.1 Japan Solid Dosage Form Drug Market Size, 2018-2029

8.6.2 By Company, Japan Solid Dosage Form Drug Revenue Market Share, 2018-2023

8.6.3 By Type, Japan Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029

8.6.4 By Application, Japan Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029

8.7 South Korea

8.7.1 South Korea Solid Dosage Form Drug Market Size, 2018-2029

8.7.2 By Company, South Korea Solid Dosage Form Drug Revenue Market Share, 2018-2023

8.7.3 By Type, South Korea Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029

8.7.4 By Application, South Korea Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029

8.8 Southeast Asia

8.8.1 Southeast Asia Solid Dosage Form Drug Market Size, 2018-2029

8.8.2 By Company, Southeast Asia Solid Dosage Form Drug Revenue Market Share, 2018-2023

8.8.3 By Type, Southeast Asia Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029

8.8.4 By Application, Southeast Asia Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029

8.9 India

8.9.1 India Solid Dosage Form Drug Market Size, 2018-2029

8.9.2 By Company, India Solid Dosage Form Drug Revenue Market Share, 2018-2023

8.9.3 By Type, India Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029

8.9.4 By Application, India Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029

8.10 Middle East & Asia

8.10.1 Middle East & Asia Solid Dosage Form Drug Market Size, 2018-2029

8.10.2 By Company, Middle East & Asia Solid Dosage Form Drug Revenue Market Share, 2018-2023

8.10.3 By Type, Middle East & Asia Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029

8.10.4 By Application, Middle East & Asia Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029

9 Global Manufacturers Profile

9.1 Johnson & Johnson

9.1.1 Johnson & Johnson Company Information, Head Office, Market Area and Industry Position

9.1.2 Johnson & Johnson Company Profile and Main Business

9.1.3 Johnson & Johnson Solid Dosage Form Drug Models, Specifications and Application

9.1.4 Johnson & Johnson Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023

9.1.5 Johnson & Johnson Recent Developments

9.2 Novartis

9.2.1 Novartis Company Information, Head Office, Market Area and Industry Position

9.2.2 Novartis Company Profile and Main Business

9.2.3 Novartis Solid Dosage Form Drug Models, Specifications and Application

9.2.4 Novartis Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023

9.2.5 Novartis Recent Developments

9.3 Roche

9.3.1 Roche Company Information, Head Office, Market Area and Industry Position

9.3.2 Roche Company Profile and Main Business

9.3.3 Roche Solid Dosage Form Drug Models, Specifications and Application

9.3.4 Roche Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023

9.3.5 Roche Recent Developments

9.4 AbbVie

9.4.1 AbbVie Company Information, Head Office, Market Area and Industry Position

9.4.2 AbbVie Company Profile and Main Business

9.4.3 AbbVie Solid Dosage Form Drug Models, Specifications and Application

9.4.4 AbbVie Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023

9.4.5 AbbVie Recent Developments

9.5 Merck & Co.

9.5.1 Merck & Co. Company Information, Head Office, Market Area and Industry Position

9.5.2 Merck & Co. Company Profile and Main Business

9.5.3 Merck & Co. Solid Dosage Form Drug Models, Specifications and Application

9.5.4 Merck & Co. Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023

9.5.5 Merck & Co. Recent Developments

9.6 Bristol Myers Squibb

9.6.1 Bristol Myers Squibb Company Information, Head Office, Market Area and Industry Position

9.6.2 Bristol Myers Squibb Company Profile and Main Business

9.6.3 Bristol Myers Squibb Solid Dosage Form Drug Models, Specifications and Application

9.6.4 Bristol Myers Squibb Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023

9.6.5 Bristol Myers Squibb Recent Developments

9.7 GlaxoSmithKline

9.7.1 GlaxoSmithKline Company Information, Head Office, Market Area and Industry Position

9.7.2 GlaxoSmithKline Company Profile and Main Business

9.7.3 GlaxoSmithKline Solid Dosage Form Drug Models, Specifications and Application

9.7.4 GlaxoSmithKline Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023

9.7.5 GlaxoSmithKline Recent Developments

9.8 Pfizer

9.8.1 Pfizer Company Information, Head Office, Market Area and Industry Position

9.8.2 Pfizer Company Profile and Main Business

9.8.3 Pfizer Solid Dosage Form Drug Models, Specifications and Application

9.8.4 Pfizer Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023

9.8.5 Pfizer Recent Developments

9.9 Sanofi

9.9.1 Sanofi Company Information, Head Office, Market Area and Industry Position

9.9.2 Sanofi Company Profile and Main Business

9.9.3 Sanofi Solid Dosage Form Drug Models, Specifications and Application

9.9.4 Sanofi Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023

9.9.5 Sanofi Recent Developments

9.10 Takeda

9.10.1 Takeda Company Information, Head Office, Market Area and Industry Position

9.10.2 Takeda Company Profile and Main Business

9.10.3 Takeda Solid Dosage Form Drug Models, Specifications and Application

9.10.4 Takeda Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023

9.10.5 Takeda Recent Developments

9.11 AstraZeneca

9.11.1 AstraZeneca Company Information, Head Office, Market Area and Industry Position

9.11.2 AstraZeneca Company Profile and Main Business

9.11.3 AstraZeneca Solid Dosage Form Drug Models, Specifications and Application

9.11.4 AstraZeneca Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023

9.11.5 AstraZeneca Recent Developments

9.12 Bayer

9.12.1 Bayer Company Information, Head Office, Market Area and Industry Position

9.12.2 Bayer Company Profile and Main Business

9.12.3 Bayer Solid Dosage Form Drug Models, Specifications and Application

9.12.4 Bayer Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023

9.12.5 Bayer Recent Developments

9.13 Eli Lilly & Co.

9.13.1 Eli Lilly & Co. Company Information, Head Office, Market Area and Industry Position

9.13.2 Eli Lilly & Co. Company Profile and Main Business

9.13.3 Eli Lilly & Co. Solid Dosage Form Drug Models, Specifications and Application

9.13.4 Eli Lilly & Co. Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023

9.13.5 Eli Lilly & Co. Recent Developments

9.14 Gilead Sciences

9.14.1 Gilead Sciences Company Information, Head Office, Market Area and Industry Position

9.14.2 Gilead Sciences Company Profile and Main Business

9.14.3 Gilead Sciences Solid Dosage Form Drug Models, Specifications and Application

9.14.4 Gilead Sciences Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023

9.14.5 Gilead Sciences Recent Developments

9.15 Amgen

9.15.1 Amgen Company Information, Head Office, Market Area and Industry Position

9.15.2 Amgen Company Profile and Main Business

9.15.3 Amgen Solid Dosage Form Drug Models, Specifications and Application

9.15.4 Amgen Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023

9.15.5 Amgen Recent Developments

9.16 Teva

9.16.1 Teva Company Information, Head Office, Market Area and Industry Position

9.16.2 Teva Company Profile and Main Business

9.16.3 Teva Solid Dosage Form Drug Models, Specifications and Application

9.16.4 Teva Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023

9.16.5 Teva Recent Developments

9.17 Boehringer Ingelheim

9.17.1 Boehringer Ingelheim Company Information, Head Office, Market Area and Industry Position

9.17.2 Boehringer Ingelheim Company Profile and Main Business

9.17.3 Boehringer Ingelheim Solid Dosage Form Drug Models, Specifications and Application

9.17.4 Boehringer Ingelheim Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023

9.17.5 Boehringer Ingelheim Recent Developments

9.18 Biogen

9.18.1 Biogen Company Information, Head Office, Market Area and Industry Position

9.18.2 Biogen Company Profile and Main Business

9.18.3 Biogen Solid Dosage Form Drug Models, Specifications and Application

9.18.4 Biogen Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023

9.18.5 Biogen Recent Developments

9.19 Astellas

9.19.1 Astellas Company Information, Head Office, Market Area and Industry Position

9.19.2 Astellas Company Profile and Main Business

9.19.3 Astellas Solid Dosage Form Drug Models, Specifications and Application

9.19.4 Astellas Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023

9.19.5 Astellas Recent Developments

10 Conclusion

11 Appendix

11.1 Research Methodology

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Market Estimation Model

11.4 Disclaimer

Table 1. Solid Dosage Form Drug Market Size & CAGR: China VS Global, (US$ Million), 2018-2029

Table 2. Solid Dosage Form Drug Market Restraints

Table 3. Solid Dosage Form Drug Market Trends

Table 4. Solid Dosage Form Drug Industry Policy

Table 5. Global Solid Dosage Form Drug Revenue by Company (2018-2023) & (US$ million)

Table 6. Global Solid Dosage Form Drug Revenue Market Share by Company (2018-2023)

Table 7. Global Solid Dosage Form Drug Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Solid Dosage Form Drug Mergers & Acquisitions, Expansion Plans

Table 9. Global Solid Dosage Form Drug Manufacturers Product Type

Table 10. China Solid Dosage Form Drug Revenue by Company (2018-2023) & (US$ million)

Table 11. China Solid Dosage Form Drug Revenue Market Share by Company (2018-2023)

Table 12. Global Key Players of Solid Dosage Form Drug Upstream (Raw Materials)

Table 13. Global Solid Dosage Form Drug Typical Customers

Table 14. Solid Dosage Form Drug Typical Distributors

Table 15. By Type, Global Solid Dosage Form Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 16. By Application, Global Solid Dosage Form Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 17. By Region, Global Solid Dosage Form Drug Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 18. By Region, Global Solid Dosage Form Drug Revenue, 2018-2029, US$ Million

Table 19. By Country, Global Solid Dosage Form Drug Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 20. By Country, Global Solid Dosage Form Drug Revenue, 2018-2029, US$ Million

Table 21. By Country, Global Solid Dosage Form Drug Revenue Market Share, 2018-2029

Table 22. Johnson & Johnson Company Information, Head Office, Market Area and Industry Position

Table 23. Johnson & Johnson Company Profile and Main Business

Table 24. Johnson & Johnson Solid Dosage Form Drug Models, Specifications and Application

Table 25. Johnson & Johnson Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023

Table 26. Johnson & Johnson Recent Developments

Table 27. Novartis Company Information, Head Office, Market Area and Industry Position

Table 28. Novartis Company Profile and Main Business

Table 29. Novartis Solid Dosage Form Drug Models, Specifications and Application

Table 30. Novartis Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023

Table 31. Novartis Recent Developments

Table 32. Roche Company Information, Head Office, Market Area and Industry Position

Table 33. Roche Company Profile and Main Business

Table 34. Roche Solid Dosage Form Drug Models, Specifications and Application

Table 35. Roche Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023

Table 36. Roche Recent Developments

Table 37. AbbVie Company Information, Head Office, Market Area and Industry Position

Table 38. AbbVie Company Profile and Main Business

Table 39. AbbVie Solid Dosage Form Drug Models, Specifications and Application

Table 40. AbbVie Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023

Table 41. AbbVie Recent Developments

Table 42. Merck & Co. Company Information, Head Office, Market Area and Industry Position

Table 43. Merck & Co. Company Profile and Main Business

Table 44. Merck & Co. Solid Dosage Form Drug Models, Specifications and Application

Table 45. Merck & Co. Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023

Table 46. Merck & Co. Recent Developments

Table 47. Bristol Myers Squibb Company Information, Head Office, Market Area and Industry Position

Table 48. Bristol Myers Squibb Company Profile and Main Business

Table 49. Bristol Myers Squibb Solid Dosage Form Drug Models, Specifications and Application

Table 50. Bristol Myers Squibb Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023

Table 51. Bristol Myers Squibb Recent Developments

Table 52. GlaxoSmithKline Company Information, Head Office, Market Area and Industry Position

Table 53. GlaxoSmithKline Company Profile and Main Business

Table 54. GlaxoSmithKline Solid Dosage Form Drug Models, Specifications and Application

Table 55. GlaxoSmithKline Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023

Table 56. GlaxoSmithKline Recent Developments

Table 57. Pfizer Company Information, Head Office, Market Area and Industry Position

Table 58. Pfizer Company Profile and Main Business

Table 59. Pfizer Solid Dosage Form Drug Models, Specifications and Application

Table 60. Pfizer Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023

Table 61. Pfizer Recent Developments

Table 62. Sanofi Company Information, Head Office, Market Area and Industry Position

Table 63. Sanofi Company Profile and Main Business

Table 64. Sanofi Solid Dosage Form Drug Models, Specifications and Application

Table 65. Sanofi Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023

Table 66. Sanofi Recent Developments

Table 67. Takeda Company Information, Head Office, Market Area and Industry Position

Table 68. Takeda Company Profile and Main Business

Table 69. Takeda Solid Dosage Form Drug Models, Specifications and Application

Table 70. Takeda Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023

Table 71. Takeda Recent Developments

Table 72. AstraZeneca Company Information, Head Office, Market Area and Industry Position

Table 73. AstraZeneca Company Profile and Main Business

Table 74. AstraZeneca Solid Dosage Form Drug Models, Specifications and Application

Table 75. AstraZeneca Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023

Table 76. AstraZeneca Recent Developments

Table 77. Bayer Company Information, Head Office, Market Area and Industry Position

Table 78. Bayer Company Profile and Main Business

Table 79. Bayer Solid Dosage Form Drug Models, Specifications and Application

Table 80. Bayer Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023

Table 81. Bayer Recent Developments

Table 82. Eli Lilly & Co. Company Information, Head Office, Market Area and Industry Position

Table 83. Eli Lilly & Co. Company Profile and Main Business

Table 84. Eli Lilly & Co. Solid Dosage Form Drug Models, Specifications and Application

Table 85. Eli Lilly & Co. Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023

Table 86. Eli Lilly & Co. Recent Developments

Table 87. Gilead Sciences Company Information, Head Office, Market Area and Industry Position

Table 88. Gilead Sciences Company Profile and Main Business

Table 89. Gilead Sciences Solid Dosage Form Drug Models, Specifications and Application

Table 90. Gilead Sciences Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023

Table 91. Gilead Sciences Recent Developments

Table 92. Amgen Company Information, Head Office, Market Area and Industry Position

Table 93. Amgen Company Profile and Main Business

Table 94. Amgen Solid Dosage Form Drug Models, Specifications and Application

Table 95. Amgen Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023

Table 96. Amgen Recent Developments

Table 97. Teva Company Information, Head Office, Market Area and Industry Position

Table 98. Teva Company Profile and Main Business

Table 99. Teva Solid Dosage Form Drug Models, Specifications and Application

Table 100. Teva Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023

Table 101. Teva Recent Developments

Table 102. Boehringer Ingelheim Company Information, Head Office, Market Area and Industry Position

Table 103. Boehringer Ingelheim Company Profile and Main Business

Table 104. Boehringer Ingelheim Solid Dosage Form Drug Models, Specifications and Application

Table 105. Boehringer Ingelheim Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023

Table 106. Boehringer Ingelheim Recent Developments

Table 107. Biogen Company Information, Head Office, Market Area and Industry Position

Table 108. Biogen Company Profile and Main Business

Table 109. Biogen Solid Dosage Form Drug Models, Specifications and Application

Table 110. Biogen Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023

Table 111. Biogen Recent Developments

Table 112. Astellas Company Information, Head Office, Market Area and Industry Position

Table 113. Astellas Company Profile and Main Business

Table 114. Astellas Solid Dosage Form Drug Models, Specifications and Application

Table 115. Astellas Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023

Table 116. Astellas Recent Developments

List of Figure

Figure 1. Solid Dosage Form Drug Picture

Figure 2. Global Solid Dosage Form Drug Industry Market Size and Forecast (US$ million) & (2018-2029)

Figure 3. China Solid Dosage Form Drug Revenue and Forecast (US$ million) & (2018-2029)

Figure 4. 2018-2029 China Solid Dosage Form Drug Market Share of Global

Figure 5. Global Solid Dosage Form Drug Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 6. Global Solid Dosage Form Drug Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023

Figure 7. China Solid Dosage Form Drug Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 8. China Solid Dosage Form Drug Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 9. Solid Dosage Form Drug Industry Chain

Figure 10. Tablet

Figure 11. Capsules

Figure 12. Other

Figure 13. By Type, Global Solid Dosage Form Drug Revenue, 2018-2029, US$ Million

Figure 14. By Type, Global Solid Dosage Form Drug Revenue Market Share, 2018-2029

Figure 15. Hospital

Figure 16. Retail Pharmacy

Figure 17. Other

Figure 18. By Application, Global Solid Dosage Form Drug Revenue, 2018-2029, US$ Million

Figure 19. By Application, Global Solid Dosage Form Drug Revenue Market Share, 2018-2029

Figure 20. By Region, Global Solid Dosage Form Drug Revenue Market Share, 2018-2029

Figure 21. North America Solid Dosage Form Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 22. By Country, North America Solid Dosage Form Drug Revenue Market Share, 2018-2023

Figure 23. Europe Solid Dosage Form Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 24. By Country, Europe Solid Dosage Form Drug Revenue Market Share, 2018-2023

Figure 25. Asia Pacific Solid Dosage Form Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 26. By Country/Region, Asia Pacific Solid Dosage Form Drug Revenue Market Share, 2018-2023

Figure 27. South America Solid Dosage Form Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 28. By Country, South America Solid Dosage Form Drug Revenue Market Share, 2018-2023

Figure 29. Middle East & Africa Solid Dosage Form Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 30. U.S. Solid Dosage Form Drug Revenue, 2018-2029, (US$ Million)

Figure 31. By Company, U.S. Solid Dosage Form Drug Market Share, 2018-2023

Figure 32. By Type, U.S. Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029

Figure 33. By Application, U.S. Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029

Figure 34. Europe Solid Dosage Form Drug Revenue, 2018-2029, (US$ Million)

Figure 35. By Company, Europe Solid Dosage Form Drug Market Share, 2018-2023

Figure 36. By Type, Europe Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029

Figure 37. By Application, Europe Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029

Figure 38. China Solid Dosage Form Drug Revenue, 2018-2029, (US$ Million)

Figure 39. By Company, China Solid Dosage Form Drug Market Share, 2018-2023

Figure 40. By Type, China Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029

Figure 41. By Application, China Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029

Figure 42. Japan Solid Dosage Form Drug Revenue, 2018-2029, (US$ Million)

Figure 43. By Company, Japan Solid Dosage Form Drug Market Share, 2018-2023

Figure 44. By Type, Japan Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029

Figure 45. By Application, Japan Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029

Figure 46. South Korea Solid Dosage Form Drug Revenue, 2018-2029, (US$ Million)

Figure 47. By Company, South Korea Solid Dosage Form Drug Market Share, 2018-2023

Figure 48. By Type, South Korea Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029

Figure 49. By Application, South Korea Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029

Figure 50. Southeast Asia Solid Dosage Form Drug Revenue, 2018-2029, (US$ Million)

Figure 51. By Company, Southeast Asia Solid Dosage Form Drug Market Share, 2018-2023

Figure 52. By Type, Southeast Asia Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029

Figure 53. By Application, Southeast Asia Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029

Figure 54. India Solid Dosage Form Drug Revenue, 2018-2029, (US$ Million)

Figure 55. By Company, India Solid Dosage Form Drug Market Share, 2018-2023

Figure 56. By Type, India Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029

Figure 57. By Application, India Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029

Figure 58. Middle East & Asia Solid Dosage Form Drug Revenue, 2018-2029, (US$ Million)

Figure 59. By Company, Middle East & Asia Solid Dosage Form Drug Market Share, 2018-2023

Figure 60. By Type, Middle East & Asia Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029

Figure 61. By Application, Middle East & Asia Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029

Figure 62. Research Methodology

Figure 63. Breakdown of Primary Interviews

Figure 64. Bottom-up Approaches

Figure 65. Top-down Approaches

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)